FAMILIAL PROSTATE CANCER: CLINICAL EXOME PANEL (Sec. & CNVs) – 33 genes
LabGenetics
Delivery time
3-4 weeks
Sample
Blood
The Familial Prostate Cancer Panel identifies germline mutations that increase the risk of developing hereditary prostate cancer, including aggressive, early-onset, or familial forms. It evaluates genes involved in DNA repair, cell cycle regulation, and hormonal response, as well as in hereditary cancer syndromes, such as those related to BRCA1, BRCA2, ATM, CHEK2, PALB2, HOXB13, TP53, MSH2, MSH6, and PTEN. This test is essential for genetic diagnosis, preventive management, and the use of targeted therapies (e.g., PARP inhibitors and personalized hormonal treatments). Genes analyzed: BRCA1, BRCA2, ATM, CHEK2, PALB2, HOXB13, TP53, MSH2, PTEN, and others. You can obtain the complete list of analyzed genes by contacting Genotica.
Other tests
Preventive health test - AboutMe EXOME
545,00€
NEUROFIBROMATOSIS: GENES SMARCB1 Y LZTR1 (NGS-Sec) – ATG Medical
600,00€
Custom sequencing panels (1 to 15 genes)
660,00€